EGFR and non-small cell lung carcinoma: The selection of specific gene pairs such as EGFR–ALK, EGFR–ROS1, and EML4–ROS1 was informed by their recognized role as oncogenic drivers in NSCLC and their clinical relevance in targeted therapy.